Correlation Between Dermata Therapeutics and Zoetis

Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Zoetis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Zoetis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dermata Therapeutics and Zoetis Inc, you can compare the effects of market volatilities on Dermata Therapeutics and Zoetis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Zoetis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Zoetis.

Diversification Opportunities for Dermata Therapeutics and Zoetis

-0.43

Correlation Coefficient

Dermata Therapeutics  Zoetis

Very good diversification

The 3 months correlation between Dermata and Zoetis is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Zoetis Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zoetis Inc and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Zoetis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zoetis Inc has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Zoetis go up and down completely randomly.

Pair Corralation between Dermata Therapeutics and Zoetis

Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the Zoetis. In addition to that, Dermata Therapeutics is 5.25 times more volatile than Zoetis Inc. It trades about -0.12 of its total potential returns per unit of risk. Zoetis Inc is currently generating about 0.0 per unit of volatility. If you would invest  17,130  in Zoetis Inc on March 28, 2024 and sell it today you would lose (40.00) from holding Zoetis Inc or give up 0.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Dermata Therapeutics  vs.  Zoetis Inc

Dermata Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dermata Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in July 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Zoetis Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zoetis Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Zoetis is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Dermata Therapeutics and Zoetis

The main advantage of trading using opposite Dermata Therapeutics and Zoetis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Zoetis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zoetis will offset losses from the drop in Zoetis' long position.

The idea behind Dermata Therapeutics and Zoetis Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.